OptiNose OPTN
$ 0.48
21.72%
Quarterly report 2024-Q3
added 11-12-2024
OptiNose Balance Sheet 2011-2024 | OPTN
Annual Balance Sheet OptiNose
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-72.2 M | -91.6 M | - | -16.8 M | -71.5 M | -128 M | -163 M | -21.5 M | -718 K | - | - | - | - |
Long Term Debt |
611 K | 625 K | 126 M | 125 M | 74.5 M | 72.5 M | 71.9 M | 15.3 M | 14.5 M | - | - | - | - |
Long Term Debt Current |
911 K | 1.97 M | 2.09 M | 2.11 M | 1.14 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 130 M | 74.9 M | 72.7 M | 71.9 M | 39.5 M | 36 M | - | - | - | - |
Total Current Liabilities |
177 M | 179 M | 59.2 M | 52.2 M | 36.1 M | 25.7 M | 14.8 M | - | - | - | - | - | - |
Total Liabilities |
194 M | 201 M | 188 M | 182 M | 111 M | 98.4 M | 86.6 M | 45.4 M | 43.2 M | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | 160 K | 186 K | - | 41 K | - | - | - | - |
Retained Earnings |
-720 M | -685 M | -610 M | -528 M | -428 M | -318 M | -211 M | -151 M | -161 M | - | - | - | - |
Total Assets |
108 M | 144 M | 166 M | 189 M | 173 M | 217 M | 241 M | 41.6 M | 16 M | - | - | - | - |
Cash and Cash Equivalents |
73.7 M | 94.2 M | 111 M | 144 M | 147 M | 201 M | 235 M | 36.8 M | - | - | - | - | - |
Book Value |
-86.6 M | -56.6 M | -21.8 M | 6.79 M | 61.6 M | 119 M | 154 M | -3.84 M | -27.1 M | - | - | - | - |
Total Shareholders Equity |
-86.6 M | -56.6 M | -21.8 M | 6.79 M | 61.6 M | 119 M | 154 M | -151 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet OptiNose
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 125 M | 131 M | - | - | - | - | - | - | 127 M | 127 M | 126 M | 127 M | 126 M | 126 M | 125 M | 105 M | 125 M | 125 M | 74.5 M | 74.3 M | 74.5 M | 74.5 M | 72.5 M | 72.3 M | 72.5 M | 72.5 M | 71.9 M | - | 71.9 M | 71.9 M | - | 15.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
172 M | 175 M | 183 M | 194 M | 179 M | 176 M | 189 M | 201 M | 179 M | 184 M | 179 M | 188 M | 183 M | 177 M | 175 M | 182 M | 182 M | 182 M | 182 M | 111 M | 111 M | 111 M | 111 M | 98.4 M | 98.4 M | 98.4 M | 98.4 M | 86.6 M | 86.6 M | 86.6 M | 86.6 M | 24.6 M | 24.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 160 K | 160 K | 160 K | - | 186 K | 217 K | 186 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-742 M | -742 M | -734 M | -720 M | -710 M | -701 M | -704 M | -685 M | -670 M | -655 M | -635 M | -610 M | -594 M | -577 M | -554 M | -528 M | -528 M | -528 M | -528 M | -428 M | -428 M | -428 M | -428 M | -318 M | -318 M | -318 M | -318 M | -211 M | -211 M | -211 M | -211 M | -151 M | -151 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
131 M | 132 M | 83.7 M | 108 M | 101 M | 106 M | 115 M | 144 M | 105 M | 123 M | 134 M | 166 M | 132 M | 140 M | 158 M | 189 M | 189 M | 189 M | 189 M | 173 M | 173 M | 173 M | 173 M | 217 M | 217 M | 217 M | 217 M | 241 M | 241 M | 241 M | 241 M | 41.6 M | 41.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
82.5 M | 91.4 M | 51.6 M | 73.7 M | 66.8 M | 71.3 M | 83.9 M | 94.2 M | 61.1 M | 78.3 M | 91.4 M | 111 M | 84.2 M | 93.9 M | 116 M | 144 M | 144 M | 144 M | 144 M | 147 M | 147 M | 147 M | 147 M | 201 M | 201 M | 201 M | 201 M | 235 M | 49.4 M | 235 M | 235 M | 36.8 M | 36.8 M | - | - | 15.2 M | - | - | - | 24.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-41.1 M | -42.9 M | -99.2 M | -86.6 M | -77.6 M | -69.7 M | -73.8 M | -56.6 M | -73.4 M | -60.8 M | -44.9 M | -21.8 M | -51.5 M | -37.1 M | -16.7 M | 6.79 M | 6.79 M | 6.79 M | 6.79 M | 61.6 M | 61.6 M | 61.6 M | 61.6 M | 119 M | 119 M | 119 M | 119 M | 154 M | 154 M | 154 M | 154 M | 17 M | 17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-41.1 M | -42.9 M | -99.2 M | -86.6 M | -77.6 M | -69.7 M | -73.8 M | -56.6 M | -73.4 M | -60.8 M | -44.9 M | -21.8 M | -51.5 M | -37.1 M | -16.7 M | 6.79 M | 6.79 M | 6.79 M | 6.79 M | 61.6 M | 61.6 M | 61.6 M | 61.6 M | 119 M | 119 M | 119 M | 119 M | 154 M | 154 M | 154 M | 154 M | -151 M | -151 M | - | - | -161 M | - | - | - | -122 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency